1. Government of Canada. Pfizer-BioNTech COVID-19 Vaccine (tozinameran) [Internet]. Ottawa (ON): Government of Canada; 2020 Dec 9 [updated 2020 Dec 11; cited 2020 Dec 11]. Available from: https://covid-vaccine.canada.ca/pfizer-biontech-covid-19-vaccine/product-details
2. Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations;Expert Rev Vaccines,2020
3. Key populations for early COVID-19 immunization: preliminary guidance for policy
4. National Advisory Committee on Immunization. Guidance on the prioritization of initial doses of COVID-19 vaccine(s) [Internet]. Ottawa (ON): Government of Canada; 2020 [updated 2020 Dec 4; cited 2020 Dec 14]. Available from: https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-prioritization-initial-doses-covid-19-vaccines.html
5. Frank K , Arim R. Canadians’ willingness to get a COVID-19 vaccine: Group differences and reasons for vaccine hesitancy [Internet]. Ottawa (ON): Statistics Canada; 2020 Aug 25 [cited 2020 Dec 11]. Available from: https://www150.statcan.gc.ca/n1/pub/45-28-0001/2020001/article/00073-eng.htm